nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—ovarian cancer	0.459	0.857	CbGaD
Acetylsalicylic acid—ABCB1—ovarian cancer	0.0764	0.143	CbGaD
Acetylsalicylic acid—SLC22A7—Docetaxel—ovarian cancer	0.0375	0.317	CbGbCtD
Acetylsalicylic acid—ABCB1—Topotecan—ovarian cancer	0.0199	0.168	CbGbCtD
Acetylsalicylic acid—CYP2C8—Paclitaxel—ovarian cancer	0.0145	0.123	CbGbCtD
Acetylsalicylic acid—ABCB1—Vinorelbine—ovarian cancer	0.014	0.118	CbGbCtD
Acetylsalicylic acid—CYP2C9—Paclitaxel—ovarian cancer	0.0101	0.0856	CbGbCtD
Acetylsalicylic acid—ABCB1—Paclitaxel—ovarian cancer	0.00983	0.0831	CbGbCtD
Acetylsalicylic acid—ABCB1—Docetaxel—ovarian cancer	0.0071	0.0601	CbGbCtD
Acetylsalicylic acid—TP53—oviduct—ovarian cancer	0.00567	0.0563	CbGeAlD
Acetylsalicylic acid—HSPA5—oviduct—ovarian cancer	0.00547	0.0542	CbGeAlD
Acetylsalicylic acid—ABCB1—Doxorubicin—ovarian cancer	0.0053	0.0448	CbGbCtD
Acetylsalicylic acid—PTGS2—ovarian follicle—ovarian cancer	0.00249	0.0247	CbGeAlD
Acetylsalicylic acid—TP53—myometrium—ovarian cancer	0.00182	0.018	CbGeAlD
Acetylsalicylic acid—NFKBIA—myometrium—ovarian cancer	0.00179	0.0177	CbGeAlD
Acetylsalicylic acid—HSPA5—myometrium—ovarian cancer	0.00175	0.0173	CbGeAlD
Acetylsalicylic acid—TP53—embryo—ovarian cancer	0.00175	0.0173	CbGeAlD
Acetylsalicylic acid—NFKBIA—embryo—ovarian cancer	0.00172	0.017	CbGeAlD
Acetylsalicylic acid—HSPA5—embryo—ovarian cancer	0.00168	0.0167	CbGeAlD
Acetylsalicylic acid—RPS6KA3—myometrium—ovarian cancer	0.00149	0.0148	CbGeAlD
Acetylsalicylic acid—RPS6KA3—embryo—ovarian cancer	0.00143	0.0142	CbGeAlD
Acetylsalicylic acid—TP53—epithelium—ovarian cancer	0.00142	0.0141	CbGeAlD
Acetylsalicylic acid—TP53—uterine cervix—ovarian cancer	0.00141	0.014	CbGeAlD
Acetylsalicylic acid—NFKBIA—epithelium—ovarian cancer	0.0014	0.0139	CbGeAlD
Acetylsalicylic acid—NFKBIA—uterine cervix—ovarian cancer	0.00139	0.0138	CbGeAlD
Acetylsalicylic acid—HSPA5—epithelium—ovarian cancer	0.00137	0.0136	CbGeAlD
Acetylsalicylic acid—HSPA5—uterine cervix—ovarian cancer	0.00136	0.0135	CbGeAlD
Acetylsalicylic acid—TP53—decidua—ovarian cancer	0.00135	0.0133	CbGeAlD
Acetylsalicylic acid—NFKBIA—decidua—ovarian cancer	0.00132	0.0131	CbGeAlD
Acetylsalicylic acid—HSPA5—decidua—ovarian cancer	0.0013	0.0129	CbGeAlD
Acetylsalicylic acid—TP53—endometrium—ovarian cancer	0.00128	0.0127	CbGeAlD
Acetylsalicylic acid—NFKBIA—endometrium—ovarian cancer	0.00126	0.0125	CbGeAlD
Acetylsalicylic acid—HSPA5—endometrium—ovarian cancer	0.00123	0.0122	CbGeAlD
Acetylsalicylic acid—EDNRA—myometrium—ovarian cancer	0.00121	0.012	CbGeAlD
Acetylsalicylic acid—TP53—gonad—ovarian cancer	0.00118	0.0118	CbGeAlD
Acetylsalicylic acid—TP53—uterus—ovarian cancer	0.00118	0.0117	CbGeAlD
Acetylsalicylic acid—NFKBIA—gonad—ovarian cancer	0.00117	0.0116	CbGeAlD
Acetylsalicylic acid—RPS6KA3—uterine cervix—ovarian cancer	0.00116	0.0115	CbGeAlD
Acetylsalicylic acid—NFKBIA—uterus—ovarian cancer	0.00116	0.0115	CbGeAlD
Acetylsalicylic acid—PTGS1—oviduct—ovarian cancer	0.00114	0.0113	CbGeAlD
Acetylsalicylic acid—HSPA5—gonad—ovarian cancer	0.00114	0.0113	CbGeAlD
Acetylsalicylic acid—HSPA5—uterus—ovarian cancer	0.00113	0.0112	CbGeAlD
Acetylsalicylic acid—RPS6KA3—decidua—ovarian cancer	0.0011	0.011	CbGeAlD
Acetylsalicylic acid—IKBKB—myometrium—ovarian cancer	0.0011	0.0109	CbGeAlD
Acetylsalicylic acid—TP53—female reproductive system—ovarian cancer	0.00106	0.0105	CbGeAlD
Acetylsalicylic acid—IKBKB—embryo—ovarian cancer	0.00106	0.0105	CbGeAlD
Acetylsalicylic acid—RPS6KA3—endometrium—ovarian cancer	0.00105	0.0104	CbGeAlD
Acetylsalicylic acid—NFKBIA—female reproductive system—ovarian cancer	0.00104	0.0103	CbGeAlD
Acetylsalicylic acid—HSPA5—female reproductive system—ovarian cancer	0.00102	0.0101	CbGeAlD
Acetylsalicylic acid—TP53—bone marrow—ovarian cancer	0.000999	0.00991	CbGeAlD
Acetylsalicylic acid—NFKBIA—bone marrow—ovarian cancer	0.000983	0.00975	CbGeAlD
Acetylsalicylic acid—RPS6KA3—uterus—ovarian cancer	0.000966	0.00958	CbGeAlD
Acetylsalicylic acid—TP53—female gonad—ovarian cancer	0.000963	0.00955	CbGeAlD
Acetylsalicylic acid—HSPA5—bone marrow—ovarian cancer	0.000963	0.00955	CbGeAlD
Acetylsalicylic acid—TP53—vagina—ovarian cancer	0.000957	0.00949	CbGeAlD
Acetylsalicylic acid—NFKBIA—female gonad—ovarian cancer	0.000947	0.00939	CbGeAlD
Acetylsalicylic acid—EDNRA—uterine cervix—ovarian cancer	0.000942	0.00935	CbGeAlD
Acetylsalicylic acid—NFKBIA—vagina—ovarian cancer	0.000942	0.00934	CbGeAlD
Acetylsalicylic acid—HSPA5—female gonad—ovarian cancer	0.000928	0.0092	CbGeAlD
Acetylsalicylic acid—NFKBIA—Paclitaxel—Docetaxel—ovarian cancer	0.000926	0.221	CbGdCrCtD
Acetylsalicylic acid—HSPA5—vagina—ovarian cancer	0.000922	0.00915	CbGeAlD
Acetylsalicylic acid—EDNRA—decidua—ovarian cancer	0.000898	0.0089	CbGeAlD
Acetylsalicylic acid—RPS6KA3—female reproductive system—ovarian cancer	0.000869	0.00861	CbGeAlD
Acetylsalicylic acid—IKBKB—uterine cervix—ovarian cancer	0.000856	0.00849	CbGeAlD
Acetylsalicylic acid—TP53—testis—ovarian cancer	0.000854	0.00847	CbGeAlD
Acetylsalicylic acid—EDNRA—endometrium—ovarian cancer	0.000852	0.00845	CbGeAlD
Acetylsalicylic acid—NFKBIA—testis—ovarian cancer	0.00084	0.00833	CbGeAlD
Acetylsalicylic acid—TP53—Vincristine—Vinorelbine—ovarian cancer	0.00084	0.2	CbGdCrCtD
Acetylsalicylic acid—HSPA5—testis—ovarian cancer	0.000823	0.00816	CbGeAlD
Acetylsalicylic acid—RPS6KA3—bone marrow—ovarian cancer	0.00082	0.00813	CbGeAlD
Acetylsalicylic acid—IKBKB—decidua—ovarian cancer	0.000815	0.00808	CbGeAlD
Acetylsalicylic acid—RPS6KA3—female gonad—ovarian cancer	0.00079	0.00784	CbGeAlD
Acetylsalicylic acid—RPS6KA3—vagina—ovarian cancer	0.000785	0.00779	CbGeAlD
Acetylsalicylic acid—EDNRA—uterus—ovarian cancer	0.000785	0.00779	CbGeAlD
Acetylsalicylic acid—IKBKB—endometrium—ovarian cancer	0.000774	0.00768	CbGeAlD
Acetylsalicylic acid—IKBKB—gonad—ovarian cancer	0.000718	0.00712	CbGeAlD
Acetylsalicylic acid—IKBKB—uterus—ovarian cancer	0.000713	0.00707	CbGeAlD
Acetylsalicylic acid—RPS6KA3—testis—ovarian cancer	0.000701	0.00695	CbGeAlD
Acetylsalicylic acid—EDNRA—female gonad—ovarian cancer	0.000642	0.00637	CbGeAlD
Acetylsalicylic acid—IKBKB—female reproductive system—ovarian cancer	0.000641	0.00636	CbGeAlD
Acetylsalicylic acid—EDNRA—vagina—ovarian cancer	0.000639	0.00633	CbGeAlD
Acetylsalicylic acid—NFKBIA—Vincristine—Vinorelbine—ovarian cancer	0.000636	0.152	CbGdCrCtD
Acetylsalicylic acid—TP53—lymph node—ovarian cancer	0.000619	0.00614	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymph node—ovarian cancer	0.000609	0.00604	CbGeAlD
Acetylsalicylic acid—HSPA5—lymph node—ovarian cancer	0.000597	0.00592	CbGeAlD
Acetylsalicylic acid—IKBKB—female gonad—ovarian cancer	0.000583	0.00579	CbGeAlD
Acetylsalicylic acid—IKBKB—vagina—ovarian cancer	0.00058	0.00575	CbGeAlD
Acetylsalicylic acid—EDNRA—testis—ovarian cancer	0.00057	0.00565	CbGeAlD
Acetylsalicylic acid—IKBKB—testis—ovarian cancer	0.000517	0.00513	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lymph node—ovarian cancer	0.000508	0.00504	CbGeAlD
Acetylsalicylic acid—SLC22A7—testis—ovarian cancer	0.000502	0.00498	CbGeAlD
Acetylsalicylic acid—EDNRA—lymph node—ovarian cancer	0.000413	0.0041	CbGeAlD
Acetylsalicylic acid—Respiratory failure—Docetaxel—ovarian cancer	0.000386	0.00544	CcSEcCtD
Acetylsalicylic acid—Eruption—Doxorubicin—ovarian cancer	0.000385	0.00542	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Melphalan—ovarian cancer	0.000384	0.00542	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Melphalan—ovarian cancer	0.000382	0.00539	CcSEcCtD
Acetylsalicylic acid—Hepatocellular injury—Docetaxel—ovarian cancer	0.000379	0.00535	CcSEcCtD
Acetylsalicylic acid—IKBKB—lymph node—ovarian cancer	0.000375	0.00372	CbGeAlD
Acetylsalicylic acid—Polyuria—Paclitaxel—ovarian cancer	0.00037	0.00521	CcSEcCtD
Acetylsalicylic acid—Haematemesis—Epirubicin—ovarian cancer	0.000368	0.00519	CcSEcCtD
Acetylsalicylic acid—Deafness—Paclitaxel—ovarian cancer	0.000363	0.00512	CcSEcCtD
Acetylsalicylic acid—Flushing—Melphalan—ovarian cancer	0.000355	0.005	CcSEcCtD
Acetylsalicylic acid—Anaemia—Chlorambucil—ovarian cancer	0.000353	0.00497	CcSEcCtD
Acetylsalicylic acid—Agitation—Chlorambucil—ovarian cancer	0.000351	0.00495	CcSEcCtD
Acetylsalicylic acid—PTGS2—myometrium—ovarian cancer	0.00035	0.00347	CbGeAlD
Acetylsalicylic acid—Angioedema—Chlorambucil—ovarian cancer	0.000349	0.00492	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Chlorambucil—ovarian cancer	0.000342	0.00482	CcSEcCtD
Acetylsalicylic acid—Renal impairment—Paclitaxel—ovarian cancer	0.000341	0.00481	CcSEcCtD
Acetylsalicylic acid—Haematemesis—Doxorubicin—ovarian cancer	0.000341	0.0048	CcSEcCtD
Acetylsalicylic acid—Lightheadedness—Docetaxel—ovarian cancer	0.000339	0.00478	CcSEcCtD
Acetylsalicylic acid—PTGS2—embryo—ovarian cancer	0.000336	0.00334	CbGeAlD
Acetylsalicylic acid—Hypoglycaemia—Paclitaxel—ovarian cancer	0.000333	0.00469	CcSEcCtD
Acetylsalicylic acid—Convulsion—Chlorambucil—ovarian cancer	0.000331	0.00466	CcSEcCtD
Acetylsalicylic acid—CYP2C8—endometrium—ovarian cancer	0.000318	0.00315	CbGeAlD
Acetylsalicylic acid—Confusional state—Chlorambucil—ovarian cancer	0.000314	0.00443	CcSEcCtD
Acetylsalicylic acid—Anaemia—Topotecan—ovarian cancer	0.000314	0.00443	CcSEcCtD
Acetylsalicylic acid—Angioedema—Topotecan—ovarian cancer	0.000311	0.00438	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Idarubicin—Epirubicin—ovarian cancer	0.00031	0.074	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Doxorubicin—Epirubicin—ovarian cancer	0.00031	0.074	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Epirubicin—ovarian cancer	0.00031	0.074	CbGdCrCtD
Acetylsalicylic acid—Flushing—Vinorelbine—ovarian cancer	0.00031	0.00437	CcSEcCtD
Acetylsalicylic acid—Deafness—Docetaxel—ovarian cancer	0.000308	0.00434	CcSEcCtD
Acetylsalicylic acid—Anaemia—Melphalan—ovarian cancer	0.000308	0.00434	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Chlorambucil—ovarian cancer	0.000305	0.0043	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Topotecan—ovarian cancer	0.000304	0.00429	CcSEcCtD
Acetylsalicylic acid—ALB—testis—ovarian cancer	0.000302	0.003	CbGeAlD
Acetylsalicylic acid—Leukopenia—Melphalan—ovarian cancer	0.000298	0.0042	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Paclitaxel—ovarian cancer	0.000296	0.00417	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Topotecan—ovarian cancer	0.000289	0.00408	CcSEcCtD
Acetylsalicylic acid—Chest pain—Topotecan—ovarian cancer	0.000289	0.00408	CcSEcCtD
Acetylsalicylic acid—Renal impairment—Docetaxel—ovarian cancer	0.000289	0.00408	CcSEcCtD
Acetylsalicylic acid—Convulsion—Melphalan—ovarian cancer	0.000288	0.00406	CcSEcCtD
Acetylsalicylic acid—PTGS1—epithelium—ovarian cancer	0.000287	0.00285	CbGeAlD
Acetylsalicylic acid—NFKBIA—Idarubicin—Doxorubicin—ovarian cancer	0.000287	0.0684	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Doxorubicin—ovarian cancer	0.000287	0.0684	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Epirubicin—Doxorubicin—ovarian cancer	0.000287	0.0684	CbGdCrCtD
Acetylsalicylic acid—PTGS1—uterine cervix—ovarian cancer	0.000285	0.00282	CbGeAlD
Acetylsalicylic acid—Chest pain—Melphalan—ovarian cancer	0.000283	0.00399	CcSEcCtD
Acetylsalicylic acid—Influenza—Paclitaxel—ovarian cancer	0.000281	0.00396	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Topotecan—ovarian cancer	0.000277	0.00391	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.000275	0.00388	CcSEcCtD
Acetylsalicylic acid—PTGS2—epithelium—ovarian cancer	0.000274	0.00272	CbGeAlD
Acetylsalicylic acid—Dyspepsia—Chlorambucil—ovarian cancer	0.000274	0.00387	CcSEcCtD
Acetylsalicylic acid—CYP2C19—vagina—ovarian cancer	0.000273	0.0027	CbGeAlD
Acetylsalicylic acid—PTGS2—uterine cervix—ovarian cancer	0.000272	0.0027	CbGeAlD
Acetylsalicylic acid—Anaphylactic shock—Melphalan—ovarian cancer	0.000272	0.00383	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Topotecan—ovarian cancer	0.000272	0.00383	CcSEcCtD
Acetylsalicylic acid—Ulcer—Epirubicin—ovarian cancer	0.00027	0.00381	CcSEcCtD
Acetylsalicylic acid—Anaemia—Vinorelbine—ovarian cancer	0.000269	0.00379	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Topotecan—ovarian cancer	0.000268	0.00378	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Melphalan—ovarian cancer	0.000266	0.00375	CcSEcCtD
Acetylsalicylic acid—Angioedema—Vinorelbine—ovarian cancer	0.000266	0.00375	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Melphalan—ovarian cancer	0.000265	0.00374	CcSEcCtD
Acetylsalicylic acid—CYP2C8—female reproductive system—ovarian cancer	0.000263	0.00261	CbGeAlD
Acetylsalicylic acid—Vertigo—Vinorelbine—ovarian cancer	0.000261	0.00368	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Vinorelbine—ovarian cancer	0.00026	0.00367	CcSEcCtD
Acetylsalicylic acid—PTGS1—endometrium—ovarian cancer	0.000257	0.00255	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Chlorambucil—ovarian cancer	0.000257	0.00362	CcSEcCtD
Acetylsalicylic acid—Hepatocellular injury—Epirubicin—ovarian cancer	0.000256	0.00361	CcSEcCtD
Acetylsalicylic acid—Hypertension—Vinorelbine—ovarian cancer	0.000251	0.00354	CcSEcCtD
Acetylsalicylic acid—Ulcer—Doxorubicin—ovarian cancer	0.00025	0.00353	CcSEcCtD
Acetylsalicylic acid—Melaena—Epirubicin—ovarian cancer	0.00025	0.00352	CcSEcCtD
Acetylsalicylic acid—Urticaria—Chlorambucil—ovarian cancer	0.000248	0.00349	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Vinorelbine—ovarian cancer	0.000248	0.00349	CcSEcCtD
Acetylsalicylic acid—Chest pain—Vinorelbine—ovarian cancer	0.000248	0.00349	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Topotecan—ovarian cancer	0.000247	0.00349	CcSEcCtD
Acetylsalicylic acid—PTGS2—endometrium—ovarian cancer	0.000246	0.00244	CbGeAlD
Acetylsalicylic acid—Dyspepsia—Topotecan—ovarian cancer	0.000244	0.00344	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Melphalan—ovarian cancer	0.000242	0.00341	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Melphalan—ovarian cancer	0.000239	0.00337	CcSEcCtD
Acetylsalicylic acid—CYP2C8—vagina—ovarian cancer	0.000238	0.00236	CbGeAlD
Acetylsalicylic acid—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000237	0.00335	CcSEcCtD
Acetylsalicylic acid—PTGS1—uterus—ovarian cancer	0.000237	0.00235	CbGeAlD
Acetylsalicylic acid—Hepatocellular injury—Doxorubicin—ovarian cancer	0.000237	0.00334	CcSEcCtD
Acetylsalicylic acid—Coma—Epirubicin—ovarian cancer	0.000234	0.00329	CcSEcCtD
Acetylsalicylic acid—CYP2C9—female reproductive system—ovarian cancer	0.000234	0.00232	CbGeAlD
Acetylsalicylic acid—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000232	0.00328	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Vinorelbine—ovarian cancer	0.000232	0.00326	CcSEcCtD
Acetylsalicylic acid—Melaena—Doxorubicin—ovarian cancer	0.000231	0.00326	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Chlorambucil—ovarian cancer	0.00023	0.00324	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Topotecan—ovarian cancer	0.000229	0.00322	CcSEcCtD
Acetylsalicylic acid—PTGS2—uterus—ovarian cancer	0.000227	0.00225	CbGeAlD
Acetylsalicylic acid—Haemoglobin—Paclitaxel—ovarian cancer	0.000226	0.00318	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Paclitaxel—ovarian cancer	0.000225	0.00317	CcSEcCtD
Acetylsalicylic acid—Pruritus—Chlorambucil—ovarian cancer	0.00022	0.00311	CcSEcCtD
Acetylsalicylic acid—Urticaria—Topotecan—ovarian cancer	0.00022	0.00311	CcSEcCtD
Acetylsalicylic acid—ALB—lymph node—ovarian cancer	0.000219	0.00217	CbGeAlD
Acetylsalicylic acid—ABCB1—myometrium—ovarian cancer	0.000216	0.00214	CbGeAlD
Acetylsalicylic acid—Coma—Doxorubicin—ovarian cancer	0.000216	0.00305	CcSEcCtD
Acetylsalicylic acid—Urticaria—Melphalan—ovarian cancer	0.000216	0.00304	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Epirubicin—ovarian cancer	0.000213	0.00301	CcSEcCtD
Acetylsalicylic acid—PTGS1—female reproductive system—ovarian cancer	0.000213	0.00212	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Chlorambucil—ovarian cancer	0.000213	0.00301	CcSEcCtD
Acetylsalicylic acid—CYP2C8—testis—ovarian cancer	0.000212	0.0021	CbGeAlD
Acetylsalicylic acid—Dyspnoea—Vinorelbine—ovarian cancer	0.000212	0.00298	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Paclitaxel—ovarian cancer	0.000209	0.00295	CcSEcCtD
Acetylsalicylic acid—Flushing—Paclitaxel—ovarian cancer	0.000209	0.00294	CcSEcCtD
Acetylsalicylic acid—ABCB1—embryo—ovarian cancer	0.000208	0.00206	CbGeAlD
Acetylsalicylic acid—Vascular purpura—Epirubicin—ovarian cancer	0.000208	0.00293	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Topotecan—ovarian cancer	0.000204	0.00288	CcSEcCtD
Acetylsalicylic acid—PTGS2—female reproductive system—ovarian cancer	0.000204	0.00202	CbGeAlD
Acetylsalicylic acid—Hypersensitivity—Melphalan—ovarian cancer	0.0002	0.00282	CcSEcCtD
Acetylsalicylic acid—Vomiting—Chlorambucil—ovarian cancer	0.000198	0.00279	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Doxorubicin—ovarian cancer	0.000198	0.00278	CcSEcCtD
Acetylsalicylic acid—Pruritus—Topotecan—ovarian cancer	0.000196	0.00277	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Vinorelbine—ovarian cancer	0.000196	0.00276	CcSEcCtD
Acetylsalicylic acid—Renal impairment—Epirubicin—ovarian cancer	0.000195	0.00275	CcSEcCtD
Acetylsalicylic acid—PTGS1—female gonad—ovarian cancer	0.000194	0.00192	CbGeAlD
Acetylsalicylic acid—PTGS1—vagina—ovarian cancer	0.000193	0.00191	CbGeAlD
Acetylsalicylic acid—Purpura—Epirubicin—ovarian cancer	0.000193	0.00272	CcSEcCtD
Acetylsalicylic acid—PTGS2—bone marrow—ovarian cancer	0.000192	0.00191	CbGeAlD
Acetylsalicylic acid—Pruritus—Melphalan—ovarian cancer	0.000192	0.00271	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Doxorubicin—ovarian cancer	0.000192	0.00271	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Docetaxel—ovarian cancer	0.000191	0.0027	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Docetaxel—ovarian cancer	0.00019	0.00268	CcSEcCtD
Acetylsalicylic acid—Hypoglycaemia—Epirubicin—ovarian cancer	0.00019	0.00268	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Topotecan—ovarian cancer	0.00019	0.00268	CcSEcCtD
Acetylsalicylic acid—Urticaria—Vinorelbine—ovarian cancer	0.000189	0.00266	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Melphalan—ovarian cancer	0.000186	0.00262	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.000186	0.00262	CcSEcCtD
Acetylsalicylic acid—PTGS2—female gonad—ovarian cancer	0.000186	0.00184	CbGeAlD
Acetylsalicylic acid—Nausea—Chlorambucil—ovarian cancer	0.000185	0.00261	CcSEcCtD
Acetylsalicylic acid—PTGS2—vagina—ovarian cancer	0.000184	0.00183	CbGeAlD
Acetylsalicylic acid—Dizziness—Topotecan—ovarian cancer	0.000183	0.00259	CcSEcCtD
Acetylsalicylic acid—Anaemia—Paclitaxel—ovarian cancer	0.000181	0.00255	CcSEcCtD
Acetylsalicylic acid—Renal impairment—Doxorubicin—ovarian cancer	0.000181	0.00254	CcSEcCtD
Acetylsalicylic acid—Agitation—Paclitaxel—ovarian cancer	0.00018	0.00253	CcSEcCtD
Acetylsalicylic acid—Angioedema—Paclitaxel—ovarian cancer	0.000179	0.00252	CcSEcCtD
Acetylsalicylic acid—Purpura—Doxorubicin—ovarian cancer	0.000178	0.00251	CcSEcCtD
Acetylsalicylic acid—Flushing—Docetaxel—ovarian cancer	0.000177	0.00249	CcSEcCtD
Acetylsalicylic acid—Vomiting—Topotecan—ovarian cancer	0.000176	0.00249	CcSEcCtD
Acetylsalicylic acid—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000176	0.00248	CcSEcCtD
Acetylsalicylic acid—Vertigo—Paclitaxel—ovarian cancer	0.000176	0.00248	CcSEcCtD
Acetylsalicylic acid—Syncope—Paclitaxel—ovarian cancer	0.000175	0.00247	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Paclitaxel—ovarian cancer	0.000175	0.00247	CcSEcCtD
Acetylsalicylic acid—Rash—Topotecan—ovarian cancer	0.000175	0.00247	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Vinorelbine—ovarian cancer	0.000175	0.00246	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Topotecan—ovarian cancer	0.000175	0.00246	CcSEcCtD
Acetylsalicylic acid—Vomiting—Melphalan—ovarian cancer	0.000173	0.00243	CcSEcCtD
Acetylsalicylic acid—PTGS1—testis—ovarian cancer	0.000172	0.00171	CbGeAlD
Acetylsalicylic acid—Loss of consciousness—Paclitaxel—ovarian cancer	0.000172	0.00242	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000172	0.00242	CcSEcCtD
Acetylsalicylic acid—Rash—Melphalan—ovarian cancer	0.000171	0.00241	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Melphalan—ovarian cancer	0.000171	0.00241	CcSEcCtD
Acetylsalicylic acid—ABCB1—epithelium—ovarian cancer	0.00017	0.00168	CbGeAlD
Acetylsalicylic acid—Convulsion—Paclitaxel—ovarian cancer	0.000169	0.00239	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Epirubicin—ovarian cancer	0.000169	0.00238	CcSEcCtD
Acetylsalicylic acid—Hypertension—Paclitaxel—ovarian cancer	0.000169	0.00238	CcSEcCtD
Acetylsalicylic acid—ABCB1—uterine cervix—ovarian cancer	0.000168	0.00167	CbGeAlD
Acetylsalicylic acid—Pruritus—Vinorelbine—ovarian cancer	0.000168	0.00237	CcSEcCtD
Acetylsalicylic acid—Chest pain—Paclitaxel—ovarian cancer	0.000167	0.00235	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Paclitaxel—ovarian cancer	0.000167	0.00235	CcSEcCtD
Acetylsalicylic acid—Nausea—Topotecan—ovarian cancer	0.000165	0.00232	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Vinorelbine—ovarian cancer	0.000162	0.00229	CcSEcCtD
Acetylsalicylic acid—Nausea—Melphalan—ovarian cancer	0.000161	0.00227	CcSEcCtD
Acetylsalicylic acid—Confusional state—Paclitaxel—ovarian cancer	0.000161	0.00227	CcSEcCtD
Acetylsalicylic acid—Influenza—Epirubicin—ovarian cancer	0.00016	0.00226	CcSEcCtD
Acetylsalicylic acid—Asthma—Epirubicin—ovarian cancer	0.00016	0.00226	CcSEcCtD
Acetylsalicylic acid—ABCB1—decidua—ovarian cancer	0.00016	0.00159	CbGeAlD
Acetylsalicylic acid—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00016	0.00225	CcSEcCtD
Acetylsalicylic acid—Shock—Paclitaxel—ovarian cancer	0.000157	0.00221	CcSEcCtD
Acetylsalicylic acid—Dizziness—Vinorelbine—ovarian cancer	0.000157	0.00221	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Doxorubicin—ovarian cancer	0.000156	0.0022	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000156	0.0022	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Paclitaxel—ovarian cancer	0.000156	0.0022	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000154	0.00218	CcSEcCtD
Acetylsalicylic acid—Anaemia—Docetaxel—ovarian cancer	0.000153	0.00216	CcSEcCtD
Acetylsalicylic acid—ABCB1—endometrium—ovarian cancer	0.000152	0.00151	CbGeAlD
Acetylsalicylic acid—Vomiting—Vinorelbine—ovarian cancer	0.000151	0.00213	CcSEcCtD
Acetylsalicylic acid—Rash—Vinorelbine—ovarian cancer	0.00015	0.00211	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Vinorelbine—ovarian cancer	0.000149	0.00211	CcSEcCtD
Acetylsalicylic acid—Syncope—Docetaxel—ovarian cancer	0.000149	0.0021	CcSEcCtD
Acetylsalicylic acid—Influenza—Doxorubicin—ovarian cancer	0.000148	0.00209	CcSEcCtD
Acetylsalicylic acid—Asthma—Doxorubicin—ovarian cancer	0.000148	0.00209	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Docetaxel—ovarian cancer	0.000148	0.00209	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Docetaxel—ovarian cancer	0.000146	0.00205	CcSEcCtD
Acetylsalicylic acid—Convulsion—Docetaxel—ovarian cancer	0.000144	0.00202	CcSEcCtD
Acetylsalicylic acid—Hypertension—Docetaxel—ovarian cancer	0.000143	0.00202	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Epirubicin—ovarian cancer	0.000143	0.00202	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Paclitaxel—ovarian cancer	0.000142	0.00201	CcSEcCtD
Acetylsalicylic acid—Somnolence—Paclitaxel—ovarian cancer	0.000142	0.002	CcSEcCtD
Acetylsalicylic acid—ABCB1—gonad—ovarian cancer	0.000141	0.0014	CbGeAlD
Acetylsalicylic acid—Chest pain—Docetaxel—ovarian cancer	0.000141	0.00199	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Docetaxel—ovarian cancer	0.000141	0.00199	CcSEcCtD
Acetylsalicylic acid—Nausea—Vinorelbine—ovarian cancer	0.000141	0.00199	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Paclitaxel—ovarian cancer	0.000141	0.00198	CcSEcCtD
Acetylsalicylic acid—ABCB1—uterus—ovarian cancer	0.00014	0.00139	CbGeAlD
Acetylsalicylic acid—Sweating—Epirubicin—ovarian cancer	0.000137	0.00193	CcSEcCtD
Acetylsalicylic acid—Confusional state—Docetaxel—ovarian cancer	0.000136	0.00192	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Docetaxel—ovarian cancer	0.000135	0.00191	CcSEcCtD
Acetylsalicylic acid—Shock—Docetaxel—ovarian cancer	0.000133	0.00188	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Docetaxel—ovarian cancer	0.000132	0.00187	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Doxorubicin—ovarian cancer	0.000132	0.00187	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Docetaxel—ovarian cancer	0.000132	0.00186	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Paclitaxel—ovarian cancer	0.000132	0.00185	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Epirubicin—ovarian cancer	0.000129	0.00182	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Epirubicin—ovarian cancer	0.000128	0.00181	CcSEcCtD
Acetylsalicylic acid—Sweating—Doxorubicin—ovarian cancer	0.000127	0.00179	CcSEcCtD
Acetylsalicylic acid—Urticaria—Paclitaxel—ovarian cancer	0.000127	0.00179	CcSEcCtD
Acetylsalicylic acid—ABCB1—female reproductive system—ovarian cancer	0.000126	0.00125	CbGeAlD
Acetylsalicylic acid—PTGS1—lymph node—ovarian cancer	0.000125	0.00124	CbGeAlD
Acetylsalicylic acid—Dyspnoea—Docetaxel—ovarian cancer	0.000121	0.0017	CcSEcCtD
Acetylsalicylic acid—Somnolence—Docetaxel—ovarian cancer	0.00012	0.0017	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Epirubicin—ovarian cancer	0.00012	0.00169	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Doxorubicin—ovarian cancer	0.000119	0.00168	CcSEcCtD
Acetylsalicylic acid—PTGS2—lymph node—ovarian cancer	0.000119	0.00118	CbGeAlD
Acetylsalicylic acid—Flushing—Epirubicin—ovarian cancer	0.000119	0.00168	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Docetaxel—ovarian cancer	0.000119	0.00168	CcSEcCtD
Acetylsalicylic acid—ABCB1—bone marrow—ovarian cancer	0.000119	0.00118	CbGeAlD
Acetylsalicylic acid—Haemorrhage—Doxorubicin—ovarian cancer	0.000119	0.00168	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Paclitaxel—ovarian cancer	0.000118	0.00166	CcSEcCtD
Acetylsalicylic acid—ABCB1—female gonad—ovarian cancer	0.000115	0.00114	CbGeAlD
Acetylsalicylic acid—ABCB1—vagina—ovarian cancer	0.000114	0.00113	CbGeAlD
Acetylsalicylic acid—Pruritus—Paclitaxel—ovarian cancer	0.000113	0.00159	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Docetaxel—ovarian cancer	0.000111	0.00157	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Doxorubicin—ovarian cancer	0.000111	0.00156	CcSEcCtD
Acetylsalicylic acid—Flushing—Doxorubicin—ovarian cancer	0.00011	0.00155	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Paclitaxel—ovarian cancer	0.000109	0.00154	CcSEcCtD
Acetylsalicylic acid—Dizziness—Paclitaxel—ovarian cancer	0.000106	0.00149	CcSEcCtD
Acetylsalicylic acid—Anaemia—Epirubicin—ovarian cancer	0.000103	0.00146	CcSEcCtD
Acetylsalicylic acid—Agitation—Epirubicin—ovarian cancer	0.000103	0.00145	CcSEcCtD
Acetylsalicylic acid—ABCB1—testis—ovarian cancer	0.000102	0.00101	CbGeAlD
Acetylsalicylic acid—Vomiting—Paclitaxel—ovarian cancer	0.000101	0.00143	CcSEcCtD
Acetylsalicylic acid—Rash—Paclitaxel—ovarian cancer	0.000101	0.00142	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Paclitaxel—ovarian cancer	0.000101	0.00142	CcSEcCtD
Acetylsalicylic acid—Vertigo—Epirubicin—ovarian cancer	0.0001	0.00142	CcSEcCtD
Acetylsalicylic acid—Syncope—Epirubicin—ovarian cancer	0.0001	0.00141	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Epirubicin—ovarian cancer	0.0001	0.00141	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Docetaxel—ovarian cancer	9.97e-05	0.00141	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Epirubicin—ovarian cancer	9.83e-05	0.00139	CcSEcCtD
Acetylsalicylic acid—Convulsion—Epirubicin—ovarian cancer	9.69e-05	0.00137	CcSEcCtD
Acetylsalicylic acid—Hypertension—Epirubicin—ovarian cancer	9.65e-05	0.00136	CcSEcCtD
Acetylsalicylic acid—Pruritus—Docetaxel—ovarian cancer	9.57e-05	0.00135	CcSEcCtD
Acetylsalicylic acid—Anaemia—Doxorubicin—ovarian cancer	9.56e-05	0.00135	CcSEcCtD
Acetylsalicylic acid—Chest pain—Epirubicin—ovarian cancer	9.52e-05	0.00134	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Epirubicin—ovarian cancer	9.52e-05	0.00134	CcSEcCtD
Acetylsalicylic acid—Agitation—Doxorubicin—ovarian cancer	9.51e-05	0.00134	CcSEcCtD
Acetylsalicylic acid—Nausea—Paclitaxel—ovarian cancer	9.48e-05	0.00134	CcSEcCtD
Acetylsalicylic acid—Vertigo—Doxorubicin—ovarian cancer	9.3e-05	0.00131	CcSEcCtD
Acetylsalicylic acid—Syncope—Doxorubicin—ovarian cancer	9.28e-05	0.00131	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Doxorubicin—ovarian cancer	9.26e-05	0.00131	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Docetaxel—ovarian cancer	9.26e-05	0.0013	CcSEcCtD
Acetylsalicylic acid—Confusional state—Epirubicin—ovarian cancer	9.2e-05	0.0013	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Epirubicin—ovarian cancer	9.13e-05	0.00129	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Doxorubicin—ovarian cancer	9.09e-05	0.00128	CcSEcCtD
Acetylsalicylic acid—Shock—Epirubicin—ovarian cancer	8.98e-05	0.00127	CcSEcCtD
Acetylsalicylic acid—Convulsion—Doxorubicin—ovarian cancer	8.96e-05	0.00126	CcSEcCtD
Acetylsalicylic acid—Dizziness—Docetaxel—ovarian cancer	8.95e-05	0.00126	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Epirubicin—ovarian cancer	8.93e-05	0.00126	CcSEcCtD
Acetylsalicylic acid—Hypertension—Doxorubicin—ovarian cancer	8.93e-05	0.00126	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Epirubicin—ovarian cancer	8.91e-05	0.00126	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Epirubicin—ovarian cancer	8.82e-05	0.00124	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Doxorubicin—ovarian cancer	8.81e-05	0.00124	CcSEcCtD
Acetylsalicylic acid—Chest pain—Doxorubicin—ovarian cancer	8.81e-05	0.00124	CcSEcCtD
Acetylsalicylic acid—Vomiting—Docetaxel—ovarian cancer	8.6e-05	0.00121	CcSEcCtD
Acetylsalicylic acid—Rash—Docetaxel—ovarian cancer	8.53e-05	0.0012	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Docetaxel—ovarian cancer	8.52e-05	0.0012	CcSEcCtD
Acetylsalicylic acid—Confusional state—Doxorubicin—ovarian cancer	8.51e-05	0.0012	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Doxorubicin—ovarian cancer	8.44e-05	0.00119	CcSEcCtD
Acetylsalicylic acid—Shock—Doxorubicin—ovarian cancer	8.31e-05	0.00117	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Doxorubicin—ovarian cancer	8.27e-05	0.00117	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Doxorubicin—ovarian cancer	8.24e-05	0.00116	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Doxorubicin—ovarian cancer	8.16e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Epirubicin—ovarian cancer	8.14e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Somnolence—Epirubicin—ovarian cancer	8.11e-05	0.00114	CcSEcCtD
Acetylsalicylic acid—Nausea—Docetaxel—ovarian cancer	8.04e-05	0.00113	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Epirubicin—ovarian cancer	8.03e-05	0.00113	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Doxorubicin—ovarian cancer	7.53e-05	0.00106	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Epirubicin—ovarian cancer	7.52e-05	0.00106	CcSEcCtD
Acetylsalicylic acid—Somnolence—Doxorubicin—ovarian cancer	7.51e-05	0.00106	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Doxorubicin—ovarian cancer	7.43e-05	0.00105	CcSEcCtD
Acetylsalicylic acid—ABCB1—lymph node—ovarian cancer	7.38e-05	0.000732	CbGeAlD
Acetylsalicylic acid—Urticaria—Epirubicin—ovarian cancer	7.25e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Doxorubicin—ovarian cancer	6.96e-05	0.000981	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Epirubicin—ovarian cancer	6.72e-05	0.000948	CcSEcCtD
Acetylsalicylic acid—Urticaria—Doxorubicin—ovarian cancer	6.71e-05	0.000946	CcSEcCtD
Acetylsalicylic acid—Pruritus—Epirubicin—ovarian cancer	6.46e-05	0.00091	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Epirubicin—ovarian cancer	6.24e-05	0.00088	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Doxorubicin—ovarian cancer	6.22e-05	0.000877	CcSEcCtD
Acetylsalicylic acid—Dizziness—Epirubicin—ovarian cancer	6.03e-05	0.000851	CcSEcCtD
Acetylsalicylic acid—Pruritus—Doxorubicin—ovarian cancer	5.97e-05	0.000842	CcSEcCtD
Acetylsalicylic acid—Vomiting—Epirubicin—ovarian cancer	5.8e-05	0.000818	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Doxorubicin—ovarian cancer	5.78e-05	0.000814	CcSEcCtD
Acetylsalicylic acid—Rash—Epirubicin—ovarian cancer	5.75e-05	0.000811	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Epirubicin—ovarian cancer	5.75e-05	0.00081	CcSEcCtD
Acetylsalicylic acid—Dizziness—Doxorubicin—ovarian cancer	5.58e-05	0.000787	CcSEcCtD
Acetylsalicylic acid—Nausea—Epirubicin—ovarian cancer	5.42e-05	0.000764	CcSEcCtD
Acetylsalicylic acid—Vomiting—Doxorubicin—ovarian cancer	5.37e-05	0.000757	CcSEcCtD
Acetylsalicylic acid—Rash—Doxorubicin—ovarian cancer	5.32e-05	0.00075	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Doxorubicin—ovarian cancer	5.32e-05	0.00075	CcSEcCtD
Acetylsalicylic acid—Nausea—Doxorubicin—ovarian cancer	5.02e-05	0.000707	CcSEcCtD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.62e-06	2.71e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.61e-06	2.71e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MAPK3—ovarian cancer	4.61e-06	2.71e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TP53—ovarian cancer	4.6e-06	2.7e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MAPK3—ovarian cancer	4.56e-06	2.68e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—YAP1—ovarian cancer	4.55e-06	2.67e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.55e-06	2.67e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.52e-06	2.65e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—PIK3CA—ovarian cancer	4.49e-06	2.64e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MYC—ovarian cancer	4.48e-06	2.63e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MYC—ovarian cancer	4.43e-06	2.6e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—HRAS—ovarian cancer	4.4e-06	2.58e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MAPK1—ovarian cancer	4.39e-06	2.58e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—EGFR—ovarian cancer	4.38e-06	2.58e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—VEGFA—ovarian cancer	4.36e-06	2.56e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—VEGFA—ovarian cancer	4.36e-06	2.56e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ERBB2—ovarian cancer	4.35e-06	2.56e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MAPK1—ovarian cancer	4.34e-06	2.55e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—EGFR—ovarian cancer	4.33e-06	2.55e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—PIK3CB—ovarian cancer	4.33e-06	2.54e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—PIK3CA—ovarian cancer	4.31e-06	2.53e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—STAT3—ovarian cancer	4.31e-06	2.53e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—STAT3—ovarian cancer	4.31e-06	2.53e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NRAS—ovarian cancer	4.3e-06	2.53e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NRAS—ovarian cancer	4.3e-06	2.53e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TERT—ovarian cancer	4.3e-06	2.53e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—AKT1—ovarian cancer	4.3e-06	2.53e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MTOR—ovarian cancer	4.29e-06	2.52e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PIK3CB—ovarian cancer	4.29e-06	2.52e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—FASN—ovarian cancer	4.26e-06	2.5e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—YAP1—ovarian cancer	4.25e-06	2.5e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—FASN—ovarian cancer	4.23e-06	2.49e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PPP2R1A—ovarian cancer	4.23e-06	2.48e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL6—ovarian cancer	4.21e-06	2.47e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.21e-06	2.47e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.21e-06	2.47e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—SLC5A5—ovarian cancer	4.19e-06	2.46e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	4.18e-06	2.46e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—SLC5A5—ovarian cancer	4.17e-06	2.45e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—HRAS—ovarian cancer	4.16e-06	2.44e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—KRAS—ovarian cancer	4.14e-06	2.43e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MAPK3—ovarian cancer	4.12e-06	2.42e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MAPK3—ovarian cancer	4.12e-06	2.42e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	4.12e-06	2.42e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—KRAS—ovarian cancer	4.09e-06	2.41e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.06e-06	2.38e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—SLC2A1—ovarian cancer	4.05e-06	2.38e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CDKN1B—ovarian cancer	4.03e-06	2.37e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—SLC2A1—ovarian cancer	4.02e-06	2.36e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TERT—ovarian cancer	4.01e-06	2.36e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MYC—ovarian cancer	4.01e-06	2.35e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MYC—ovarian cancer	4.01e-06	2.35e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HRAS—ovarian cancer	3.99e-06	2.34e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—IL6—ovarian cancer	3.98e-06	2.34e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CAV1—ovarian cancer	3.98e-06	2.34e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IL2—ovarian cancer	3.97e-06	2.33e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.96e-06	2.33e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL2—ovarian cancer	3.94e-06	2.32e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.94e-06	2.31e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ABCB1—ovarian cancer	3.93e-06	2.31e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MAPK1—ovarian cancer	3.92e-06	2.3e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MAPK1—ovarian cancer	3.92e-06	2.3e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—EGFR—ovarian cancer	3.92e-06	2.3e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—EGFR—ovarian cancer	3.92e-06	2.3e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CAV1—ovarian cancer	3.91e-06	2.3e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—AKT1—ovarian cancer	3.88e-06	2.28e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP1B1—ovarian cancer	3.88e-06	2.28e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP1B1—ovarian cancer	3.86e-06	2.27e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—TYMS—ovarian cancer	3.86e-06	2.26e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ESR1—ovarian cancer	3.83e-06	2.25e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CTNNB1—ovarian cancer	3.81e-06	2.24e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—PIK3CA—ovarian cancer	3.81e-06	2.24e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—FASN—ovarian cancer	3.8e-06	2.23e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6ST—ovarian cancer	3.77e-06	2.21e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—PIK3CA—ovarian cancer	3.76e-06	2.21e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—SLC5A5—ovarian cancer	3.74e-06	2.2e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.74e-06	2.2e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—FASN—ovarian cancer	3.71e-06	2.18e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CAV1—ovarian cancer	3.71e-06	2.18e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PTEN—ovarian cancer	3.71e-06	2.18e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—KRAS—ovarian cancer	3.7e-06	2.18e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—KRAS—ovarian cancer	3.7e-06	2.18e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.7e-06	2.17e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—ovarian cancer	3.68e-06	2.16e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—AKT1—ovarian cancer	3.67e-06	2.16e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SLC5A5—ovarian cancer	3.65e-06	2.14e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CG—ovarian cancer	3.62e-06	2.13e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—APC—ovarian cancer	3.62e-06	2.13e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—SLC2A1—ovarian cancer	3.61e-06	2.12e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CG—ovarian cancer	3.56e-06	2.09e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.54e-06	2.08e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SLC2A1—ovarian cancer	3.52e-06	2.07e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—AKT1—ovarian cancer	3.52e-06	2.07e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HRAS—ovarian cancer	3.52e-06	2.07e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6ST—ovarian cancer	3.52e-06	2.07e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HRAS—ovarian cancer	3.48e-06	2.04e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—FASN—ovarian cancer	3.47e-06	2.04e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP1B1—ovarian cancer	3.46e-06	2.03e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	3.44e-06	2.02e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.42e-06	2.01e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PPP2R1A—ovarian cancer	3.42e-06	2.01e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SLC5A5—ovarian cancer	3.41e-06	2e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.4e-06	2e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PIK3CA—ovarian cancer	3.4e-06	2e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PIK3CA—ovarian cancer	3.4e-06	2e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP1B1—ovarian cancer	3.38e-06	1.99e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—APC—ovarian cancer	3.38e-06	1.99e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VEGFA—ovarian cancer	3.38e-06	1.98e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL6—ovarian cancer	3.37e-06	1.98e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—NRAS—ovarian cancer	3.34e-06	1.96e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL6—ovarian cancer	3.33e-06	1.96e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—STAT3—ovarian cancer	3.32e-06	1.95e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—NRAS—ovarian cancer	3.31e-06	1.94e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SLC2A1—ovarian cancer	3.29e-06	1.93e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—ovarian cancer	3.29e-06	1.93e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—ovarian cancer	3.29e-06	1.93e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.22e-06	1.89e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—MAPK3—ovarian cancer	3.19e-06	1.88e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ABCB1—ovarian cancer	3.19e-06	1.88e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CD—ovarian cancer	3.18e-06	1.87e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ABCB1—ovarian cancer	3.18e-06	1.87e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MAPK3—ovarian cancer	3.17e-06	1.86e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP1B1—ovarian cancer	3.16e-06	1.85e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HRAS—ovarian cancer	3.15e-06	1.85e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HRAS—ovarian cancer	3.15e-06	1.85e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—TYMS—ovarian cancer	3.14e-06	1.84e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CD—ovarian cancer	3.13e-06	1.84e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—TYMS—ovarian cancer	3.12e-06	1.83e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—AKT1—ovarian cancer	3.11e-06	1.83e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CAV1—ovarian cancer	3.11e-06	1.83e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—AKT1—ovarian cancer	3.07e-06	1.81e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	3.07e-06	1.8e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.06e-06	1.8e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—MAPK1—ovarian cancer	3.04e-06	1.79e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MAPK1—ovarian cancer	3.02e-06	1.77e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EGFR—ovarian cancer	3.02e-06	1.77e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL6—ovarian cancer	3.01e-06	1.77e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL6—ovarian cancer	3.01e-06	1.77e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PPP2R1A—ovarian cancer	3e-06	1.76e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CD—ovarian cancer	2.97e-06	1.75e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.97e-06	1.74e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—KRAS—ovarian cancer	2.87e-06	1.69e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ABCB1—ovarian cancer	2.85e-06	1.67e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—KRAS—ovarian cancer	2.85e-06	1.67e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CG—ovarian cancer	2.83e-06	1.66e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ERBB2—ovarian cancer	2.81e-06	1.65e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—TYMS—ovarian cancer	2.8e-06	1.64e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	2.8e-06	1.64e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.79e-06	1.64e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—AKT1—ovarian cancer	2.78e-06	1.63e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—AKT1—ovarian cancer	2.78e-06	1.63e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MTOR—ovarian cancer	2.78e-06	1.63e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CB—ovarian cancer	2.78e-06	1.63e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—TYMS—ovarian cancer	2.73e-06	1.61e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CB—ovarian cancer	2.73e-06	1.6e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CXCL8—ovarian cancer	2.67e-06	1.57e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—PIK3CA—ovarian cancer	2.64e-06	1.55e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ERBB2—ovarian cancer	2.62e-06	1.54e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PIK3CA—ovarian cancer	2.62e-06	1.54e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDKN1B—ovarian cancer	2.6e-06	1.53e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ABCB1—ovarian cancer	2.6e-06	1.53e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MTOR—ovarian cancer	2.59e-06	1.52e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CB—ovarian cancer	2.59e-06	1.52e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—TYMS—ovarian cancer	2.55e-06	1.5e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CASP3—ovarian cancer	2.55e-06	1.5e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—ovarian cancer	2.55e-06	1.5e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL2—ovarian cancer	2.55e-06	1.5e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CAV1—ovarian cancer	2.53e-06	1.48e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CAV1—ovarian cancer	2.51e-06	1.48e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CD—ovarian cancer	2.49e-06	1.46e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCND1—ovarian cancer	2.48e-06	1.46e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CTNNB1—ovarian cancer	2.46e-06	1.45e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—HRAS—ovarian cancer	2.44e-06	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDKN1B—ovarian cancer	2.43e-06	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HRAS—ovarian cancer	2.42e-06	1.42e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.42e-06	1.42e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MMP9—ovarian cancer	2.41e-06	1.42e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.4e-06	1.41e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTEN—ovarian cancer	2.4e-06	1.41e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTEN—ovarian cancer	2.36e-06	1.39e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL6—ovarian cancer	2.32e-06	1.36e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CG—ovarian cancer	2.3e-06	1.35e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CTNNB1—ovarian cancer	2.3e-06	1.35e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CG—ovarian cancer	2.29e-06	1.34e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CAV1—ovarian cancer	2.26e-06	1.33e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PTEN—ovarian cancer	2.24e-06	1.31e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CAV1—ovarian cancer	2.2e-06	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CB—ovarian cancer	2.17e-06	1.27e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VEGFA—ovarian cancer	2.17e-06	1.27e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.16e-06	1.27e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—AKT1—ovarian cancer	2.15e-06	1.27e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—STAT3—ovarian cancer	2.14e-06	1.26e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NRAS—ovarian cancer	2.14e-06	1.26e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—AKT1—ovarian cancer	2.14e-06	1.26e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CAV1—ovarian cancer	2.06e-06	1.21e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CG—ovarian cancer	2.06e-06	1.21e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MAPK3—ovarian cancer	2.05e-06	1.2e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CD—ovarian cancer	2.02e-06	1.19e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CD—ovarian cancer	2.01e-06	1.18e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CG—ovarian cancer	2.01e-06	1.18e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—STAT3—ovarian cancer	2e-06	1.18e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NRAS—ovarian cancer	2e-06	1.17e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MYC—ovarian cancer	1.99e-06	1.17e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.97e-06	1.15e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MAPK1—ovarian cancer	1.95e-06	1.15e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EGFR—ovarian cancer	1.95e-06	1.15e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MAPK3—ovarian cancer	1.91e-06	1.12e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CG—ovarian cancer	1.87e-06	1.1e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PTEN—ovarian cancer	1.87e-06	1.1e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MYC—ovarian cancer	1.86e-06	1.09e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KRAS—ovarian cancer	1.84e-06	1.08e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MAPK1—ovarian cancer	1.82e-06	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EGFR—ovarian cancer	1.82e-06	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CD—ovarian cancer	1.81e-06	1.06e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CB—ovarian cancer	1.76e-06	1.04e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CD—ovarian cancer	1.76e-06	1.04e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CB—ovarian cancer	1.75e-06	1.03e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KRAS—ovarian cancer	1.72e-06	1.01e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CA—ovarian cancer	1.69e-06	9.94e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CA—ovarian cancer	1.67e-06	9.78e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CD—ovarian cancer	1.65e-06	9.68e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—ovarian cancer	1.64e-06	9.62e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CA—ovarian cancer	1.58e-06	9.27e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.57e-06	9.25e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HRAS—ovarian cancer	1.57e-06	9.2e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CB—ovarian cancer	1.54e-06	9.03e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTEN—ovarian cancer	1.52e-06	8.96e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTEN—ovarian cancer	1.52e-06	8.91e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6—ovarian cancer	1.5e-06	8.8e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HRAS—ovarian cancer	1.46e-06	8.58e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CB—ovarian cancer	1.44e-06	8.44e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6—ovarian cancer	1.4e-06	8.21e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AKT1—ovarian cancer	1.38e-06	8.12e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTEN—ovarian cancer	1.36e-06	7.99e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—AKT1—ovarian cancer	1.36e-06	7.99e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTEN—ovarian cancer	1.33e-06	7.8e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CA—ovarian cancer	1.32e-06	7.77e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—AKT1—ovarian cancer	1.29e-06	7.57e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTEN—ovarian cancer	1.24e-06	7.29e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—AKT1—ovarian cancer	1.08e-06	6.34e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.08e-06	6.32e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CA—ovarian cancer	1.07e-06	6.28e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CA—ovarian cancer	9.6e-07	5.64e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CA—ovarian cancer	9.37e-07	5.5e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AKT1—ovarian cancer	8.79e-07	5.16e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CA—ovarian cancer	8.75e-07	5.14e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AKT1—ovarian cancer	8.74e-07	5.13e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AKT1—ovarian cancer	7.84e-07	4.61e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AKT1—ovarian cancer	7.65e-07	4.5e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AKT1—ovarian cancer	7.15e-07	4.2e-06	CbGpPWpGaD
